Scientists dive deep into joint tissue to unlock secrets of rare arthritis
NCT ID NCT07302074
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to better understand rare forms of inflammatory arthritis, including those linked to other autoimmune diseases or cancer immunotherapy. Researchers will analyze joint tissue samples from 100 adults to compare the immune cells and molecules involved. The goal is to identify unique disease patterns that could lead to more targeted treatments in the future. No new treatments are being tested in this study.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMMUNE CHECKPOINT INHIBITOR RELATED INFLAMAMTORY ARTHRITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU Brest - Hôpital Morvan
RECRUITINGBrest, 29200, France
-
CHU bordeaux
NOT_YET_RECRUITINGBordeaux, 33404, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a gut microbiome transplant ease axial spondyloarthritis?
- Can a Bone-Sparing hip implant outperform traditional replacement?
- Can a new shoulder implant restore Pain-Free movement?
- Can a less invasive hip surgery speed up recovery?
- Which hip implant lasts longer? a Head-to-Head trial aims to find out
- Can pregnancy and neurological disease coexist safely? a new registry seeks answers